Literature DB >> 15050021

Urinary morbidity after 125I brachytherapy of the prostate.

A Henderson, S R J Bott, P Sooriakumaran, R W Laing, S E M Langley.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15050021     DOI： 10.1111/j.1464-410X.2004.4737h.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  1 in total

1.  A history of transurethral resection of the prostate should not be a contra-indication for low-dose-rate 125I prostate brachytherapy: results of a prospective Uro-GEC phase-II trial.

Authors:  Carl Salembier; Ann Henry; Bradley R Pieters; Peter Hoskin
Journal:  J Contemp Brachytherapy       Date:  2020-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.